Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

disease progression

- PMLiVE

Healthcare and the digital revolution

How can medtech companies capitalise on this digital transformation?

- PMLiVE

The future is bright

The importance of creativity and innovation in the age of the millennial

Roche Basel Switzerland

Roche gets EU okay for Avastin/Tarceva combination

Lung cancer therapy ‘significantly’ extends progression-free survival

Digital is different – why new marketing technologies require new ways of working

Digital technology: don’t be afraid to demand more

Anthill Agency

EU flag

Imbruvica wins wider European leukaemia licence

AbbVie and J&J’s first-in-class drug now approved to treat all CLL patients in the EU

EU flag

Second Remicade biosimilar given green light in Europe

Samsung Bioepis’ Flixabi provides another lower-cost treatment option

- PMLiVE

An effective commercial model for cancer care

Patient-centric cancer care

- PMLiVE

J&J gets European OK for myeloma therapy Darzalex

First-in-class immunotherapy achieved ‘significant increase’ in overall survival

- PMLiVE

Merck agrees African digital cooperation deal

Will collaborate with Germany's GIZ on new solutions for the continent

Healthcare business and operating models redefined

How critical healthcare needs can be met more efficiently and effectively

eHealth set to benefit from EC’s ‘single digital market’

Says will help European industry, researchers and public authorities

Is it possible to change behaviour virtually?

Changing behaviour requires a combination of science and art. As technology evolves, so does the breadth of mechanisms (the ‘art’) through which we can deliver science-based, behaviour-change interventions. As the...

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links